Fidelity International’s Dimension Therapeutics, Inc DMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,688,870
Closed -$10.1M 544
2017
Q3
$10.1M Hold
1,688,870
0.03% 340
2017
Q2
$2.45M Hold
1,688,870
0.01% 440
2017
Q1
$2.96M Hold
1,688,870
0.01% 443
2016
Q4
$7.35M Hold
1,688,870
0.02% 363
2016
Q3
$13.5M Hold
1,688,870
0.04% 305
2016
Q2
$10.1M Buy
+1,688,870
New +$12.9M 0.03% 330

Fidelity International's DMTX Position: Q4 2017 in Review

Fidelity International sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 1,688,870 shares — an estimated $10.1M sold.

Fidelity International first reported a position in DMTX in Q2 2016 and held it in 6 quarters. The position peaked at $13.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

  • Fidelity International reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Fidelity International sold 1,688,870 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $10.1M.
  • Fidelity International first reported a position in Dimension Therapeutics, Inc in Q2 2016 and held it in 6 quarters.
  • Fidelity International's Dimension Therapeutics, Inc position peaked at $13.5M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Fidelity International's 13F filing for Q4 2017, filed 12 Feb 2018.